Form EFFECT - Notice of Effectiveness:
SEC Accession No. 9999999995-25-001061
Accepted
2025-04-10 00:15:22
Documents
1
Effectiveness Date
2025-04-09

Document Format Files

Seq Description Document Type Size
1 primary_doc.html EFFECT  
1 primary_doc.xml EFFECT 596
  Complete submission text file 9999999995-25-001061.txt   1825
Mailing Address 217 W. MAIN STREET SOMERVILLE NJ 08876
Business Address 217 W. MAIN STREET SOMERVILLE NJ 08876 908-370-5102
ZyVersa Therapeutics, Inc. (Filer) CIK: 0001859007 (see all company filings)

EIN.: 862685744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: EFFECT | Act: 33 | File No.: 333-286396 | Film No.: 25826348
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)